Work

Ori-TTV particles enable potent in vivo CAR-T cell engineering for the treatment of hematologic malignancies and autoimmune diseases 2256860

Year: 2026

Type: article

Source: The Journal of Immunology

DOI: 10.1093/jimmun/vkag141.366

Authors: Xiaowen He, Xuhui Dong, Yongqin Li, Yanhong Xu, Xiaoming Xia, Kehua Li, Huiru Xue, Xingwu Dong

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7171493082

FWCI:

Cites:

Cited by:

Related to: